Skip to content
When the current monkeypox outbreak started, we already had efficient monkeypox vaccines and therapeutics thanks to industry collaborations with the federal government and preparedness […]
Experts urge quicker response amid rising monkeypox cases Read More »
The White House informed on Wednesday that President Joe Biden “will be joining virtually to the first meeting of the Task Force on Reproductive
Biden to sign second executive order protecting reproductive rights Read More »
A week before the August recess, Senate Democrats are pushing legislation containing anti-science drug pricing limits, which the biotech industry says will damage research
Price controls would ruin medical innovation, say state biotech organizations Read More »
President Joe Biden, who tested positive for a rebound case of COVID-19 Saturday morning, is continuing strict isolation at the White House after “unsurprisingly,
‘Rebound positivity’ lands President Biden back in isolation Read More »
A report published by the Trust for America’s Health (TFAH) on Thursday reveals that “chronic underfunding” of emergency preparedness and prevention programs damaged the
Report: US public health and preparedness faces ‘chronic underfunding’ Read More »
After more than 30 years since he was diagnosed with HIV, a 66-year-old patient is in full remission after receiving a stem cell transplant
66-year-old HIV patient cured by stem cell transplant Read More »
According to new research published today by Vital Transformation, if drug price controls under consideration in the Senate had been in place over the
Drug price controls will destroy drug development, says study Read More »
Today is World Hepatitis Day. With a person dying every 30 seconds from a hepatitis-related illness, according to the World Hepatitis Alliance, viral hepatitis
World Hepatitis Day: Can we eliminate hepatitis? Read More »
In a move to fight genetic high cholesterol, which can be fatal, biotech companies are deploying siRNA and antisense oligonucleotides, according to a new
Biotech companies develop drugs to fight genetic high cholesterol Read More »
This week, the House of Representatives might vote on a plan to prolong telehealth reimbursement flexibilities until 2024. On Tuesday, the House Rules Committee
Legislators propose prolonging telehealth flexibility until end of 2024 Read More »
